NCT03191110Active, not recruiting
The COLON Study: Colorectal Cancer Cohort
The COLON Study: Colorectal Cancer: Longitudinal, Observational Study on Nutritional and Lifestyle Factors That May Influence Colorectal Tumour Recurrence, Survival and Quality of Life
Source: ClinicalTrials.gov · Last updated 1 Apr 2025
Brief summary (registry, in English)
The main aim of this observational, prospective cohort study is to assess associations of diet and other lifestyle factors with colorectal cancer recurrence, survival and quality of life.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 9 Jun 2017
- Start date
- 3 Aug 2010
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Wageningen University
- Diseases
- Colorectal cancer, Childhood cancers
- NCT number
- NCT03191110
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 3 Aug 2010 to the primary completion date, 31 Dec 2030
- 11 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- A history of colorectal cancer or (partial) bowel resection
- Chronic inflammatory bowel disease
- Hereditary colorectal cancer syndromes (Lynch syndrome, FAP, Peutz-Jegher)
- Dementia or another mental condition that makes it impossible to fill out questionnaires
Other
- Non-Dutch speaking
Who the study is looking for
- \- Patients newly diagnosed with colorectal cancer in one of the participating hospitals
Sex: All · Does not accept healthy volunteers
Sites (11)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ziekenhuisgroep Twente Coordinator of this site? Confirm its status | Almelo | Netherlands | Unknown status |
| Gelre Hospital Coordinator of this site? Confirm its status | Apeldoorn | Netherlands | Unknown status |
| Rijnstate Hospital Coordinator of this site? Confirm its status | Arnhem | Netherlands | Unknown status |
| Slingeland Hospital Coordinator of this site? Confirm its status | Doetinchem | Netherlands | Unknown status |
| Hospital Gelderse Vallei Coordinator of this site? Confirm its status | Ede | Netherlands | Unknown status |
| Admiraal De Ruyter Hospital Coordinator of this site? Confirm its status | Goes/Vlissingen | Netherlands | Unknown status |
| Martini Hospital Coordinator of this site? Confirm its status | Groningen | Netherlands | Unknown status |
| Radboudumc Coordinator of this site? Confirm its status | Nijmegen | Netherlands | Unknown status |
| Canisius-Wilhelmina Hospital Coordinator of this site? Confirm its status | Nijmegen | Netherlands | Unknown status |
| Bernhoven Hospital Coordinator of this site? Confirm its status | Oss | Netherlands | Unknown status |
| Isala Klinieken Coordinator of this site? Confirm its status | Zwolle | Netherlands | Unknown status |
Related publications
- Vitamin D, magnesium, calcium, and their interaction in relation to colorectal cancer recurrence and all-cause mortality.Am J Clin Nutr · 2020 · PMID 32190892
- Chemotherapy and vitamin D supplement use are determinants of serum 25-hydroxyvitamin D levels during the first six months after colorectal cancer diagnosis.J Steroid Biochem Mol Biol · 2020 · PMID 31917319
This page is information, not medical advice. Discuss any trial with your doctor.